WHiTE 8 COPAL, a randomised controlled trial embedded in the World Hip Trauma Evaluation study, opened to recruitment on Friday, August 17th and recruited its first patient on the same day. WHiTE 8 will be recruiting for 30 months at 24 hospitals across the UK. The study aims to establish whether a high dose dual antibiotic regime has fewer infections compared to low dose single antibiotic cement in the treatment of cemented hemiarthroplasties in patients who have suffered a displaced intracapsular fracture of the neck of femur. For more information about the WHiTE 8 trial, please visit https://white8.octru.ox.ac.uk/